登录

Weiyun AI Brings in ¥100 million in a New Round of Financing

作者: Mailman 2021-04-13 09:06
微云人工智能
企业数据由 动脉橙 提供支持
数字化牙科C2M工业互联网运营商 | C轮 | 运营中
中国-上海
2021-06-21
融资金额:数亿人民币
金茂资本
查看

(VCBeat) Mar. 30, 2021 -- Weiyun AI, a provider of AI-powered digital dentistry services, recently announced that it has completed a new round of financing worth 100 million yuan from a number of overseas family funds and listed companies. According to Dr. Liu, the founder and CEO of Weiyun AI, the funds raised in this round will be mainly used for the upgrade of the products and the promotion of the invisible brace brand "Xiangbei".


Weiyun AI combines medical health and artificial intelligence that manufactures clinical dental products through advanced manufacturing technology, custom robots, and smart factories. The company provides digital solutions for the dental industry, with more than 1000 SKUs, covering the fields of implants, orthodontics, medical beauty and repair.


Since its inception, Weiyun AI has been recognized by investors with its intelligent dental service mode and independent R&D in smart factories. In 2019, the company has received over 100 million yuan of investment from investors such as Professor Wang Tianmiao (the director of Beihang Robotics Institute), Yarui Capital, Zhiyou Jinmiao, Alphax Partners, Focus Media and so on.


The investors of this round said, "Weiyun AI has well-integrated AI, edge computing and modern medicine to create the unmanned and smart manufacturing mode of dental materials, which reconstruct the supply chain, and formed the most complete product category in the industry. At present, Weiyun AI has millions of user data, using the 'Meituan mode' to create an efficient and accurate promotion team for online and offline marketing, with a good accumulation of online and offline channels. At the same time, it has the potential to take the place of the imported products, having a huge room for growth in the future dental and aesthetic medicine market."


Professor Wang Tianmiao said, "Weiyun AI started from the R&D of the technology of hardware and software in robotic control, algorithm, and five-axis linkage general equipment nine years ago. Through the establishment of the graphic image and artificial intelligence learning networks, a more complete technical barrier has been formed. Based on these core technology advantages, Weiyun AI then entered the clinical repair and invisible orthodontics and other medical FMCG fields, directly serving B-end clinics and C-end consumers with the formation of complete product customization and intelligent performance system. Weiyun AI has a huge space for growth in the future."

相关赛道 其它耗材
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

SinoBiom Raises ¥100 Million in Series B Financing

【首发】再生技术领导者圣博玛完成数亿元B轮融资,布局全球医美市场

BeauCare Raises ¥100M in Series D Funding Round from Fortune Capital

阿里健康背后的全盘布局解构,疫情考验下远不止医药电商

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Meinuo Weichuang Closed on a ¥10 Million Pre-A+ Financing Round

2021-04-13
下一篇

RoboCT Secures ¥10 Million in Series A Funding

2021-04-13